MedTrace Logo

Evaluation of Tobacco Treatment Strategies for Inpatient Psychiatry

NCT00968513 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 956

Last updated 2025-06-11

Study results available
· View outcomes & findings →

Summary

This study aims to evaluate, in a randomized controlled trial, tobacco treatments of varying intensities for smokers hospitalized on acute psychiatric inpatient units.

Conditions

  • Tobacco Dependence

Interventions

BEHAVIORAL

Brief Intervention

(N=416) adds a stage-based manual, computer-delivered stage-tailored individualized feedback and brief cessation counseling sessions during hospitalization and repeated at months 3 and 6, and access to 12 weeks of nicotine replacement following hospitalization

BEHAVIORAL

Extended Treatment

(N=408) builds upon our current brief treatment and provides 12 additional weeks of nicotine replacement (24 weeks total) with individualized, counselor-delivered motivational and manualized cognitive behavioral cessation treatment.

BEHAVIORAL

Usual Care

(N=132) brief cessation advice, a quit smoking guide, and nicotine replacement provided during hospitalization

Sponsors & Collaborators

Principal Investigators

  • Judith J. Prochaska, PhD, MPH · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00968513 on ClinicalTrials.gov